Apraclonidine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00964 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 17 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary hereditary glaucoma | KG + DL |
| 2 | glaucoma 1, open angle | KG + DL |
| 3 | open angle glaucoma | KG + DL |
| 4 | Axenfeld anomaly | KG + DL |
| 5 | androgen insensitivity syndrome | KG + DL |
| 6 | glaucoma | KG + DL |
| 7 | visceral calciphylaxis | KG + DL |
| 8 | biotin metabolic disease | KG + DL |
| 9 | vitamin deficiency disorder | KG + DL |
| 10 | venous thoracic outlet syndrome | KG + DL |
| 11 | arterial thoracic outlet syndrome | KG + DL |
| 12 | respiratory failure | KG + DL |
| 13 | vascular disease | KG + DL |
| 14 | blue toe syndrome | KG + DL |
| 15 | neurogenic thoracic outlet syndrome | KG + DL |
| 16 | angiodysplasia of stomach | KG + DL |
| 17 | hemangioendothelioma | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.